logo
#

Latest news with #VCAS

FIELD MEDICAL CLOSES $40 MILLION SERIES A FINANCING TO REDEFINE PULSED FIELD ABLATION FOR VENTRICULAR TACHYCARDIA
FIELD MEDICAL CLOSES $40 MILLION SERIES A FINANCING TO REDEFINE PULSED FIELD ABLATION FOR VENTRICULAR TACHYCARDIA

Malaysian Reserve

time22-04-2025

  • Business
  • Malaysian Reserve

FIELD MEDICAL CLOSES $40 MILLION SERIES A FINANCING TO REDEFINE PULSED FIELD ABLATION FOR VENTRICULAR TACHYCARDIA

CARDIFF-BY-THE-SEA, Calif., April 21, 2025 /PRNewswire/ — Field Medical Inc., a pioneer in cardiac pulsed field ablation (PFA) technology, today announced the successful closing of $40 million in Series A financing. The round includes $20 million in new capital and the conversion of $20 million in seed-round debt. Participants include several leading strategics, venture capital firms and family offices, with multiple seed investors reinvesting – underscoring strong confidence in the company's initial focus on ventricular tachycardia (VT) and the broader versatility of its technology. The funding will support the completion of two pilot studies – VCAS for VT and Field PULSE for atrial fibrillation (AF) – as well as continued development of Field's commercial PFA system and operational scale-up in preparation for VERITAS, the company's pivotal trial focused on VT. 'This financing is a pivotal milestone as we advance in redefining how electrophysiologists approach ablation therapy,' said Steven Mickelsen, M.D., founder and chief executive officer of Field Medical. 'With the support of our investors, we are accelerating the development of the FieldForce™ Ablation System, building on early clinical evidence, and moving closer to our commercial goal of expanding access to next-generation PFA solutions for cardiac ablation.' 'We are encouraged by the strong support and confidence from both new investors and our reinvesting seed-round investor base,' said Oskar Dadason, chief financial officer. 'This funding enables us to execute our strategic plan with speed and focus as we transition from early-stage innovation into commercial readiness.' Field Medical is developing transformative technology for the treatment of all cardiac arrhythmias, including VT and AF. The FieldForce Ablation System, featuring the first built-for-purpose, contact force focal PFA catheter, enables an instantaneous ablation workflow, with therapy delivered in a fraction of a second. Recent results from the VCAS (VT) and PULSE (AF) pilot studies demonstrate the system's versatility. Powered by FieldBending™, the company's proprietary technology that delivers brief, high-intensity electric fields, the System is positioned as the single, advanced solution for treating a full spectrum of cardiac arrhythmias. About Field Medical® in 2022, Field Medical is advancing next-generation pulsed field ablation (PFA) technologies to address the complex needs of modern cardiac ablation. The company is led by Dr. Steven Mickelsen, a pioneer in pulsed electric field technology and a leading innovator in the field. His foundational work in PFA established the basis for modern advancements in the technology, which Field Medical continues to refine with its groundbreaking solutions. In 2024, Field Medical's technology was recognized by the FDA with Breakthrough Device Designation and inclusion in the TAP Pilot Program. For more information, visit and follow us on LinkedIn and X. The FieldForce™ Ablation System is an investigational device and is limited by federal (or United States) law to investigational use. The Growing Prevalence of VT and AFVentricular tachycardia (VT) and atrial fibrillation (AF) are two of the most common and serious arrhythmias, contributing to stroke, heart failure, sudden cardiac death and escalating health care costs. VT and premature ventricular contractions (PVCs) affect more than 6 million people in the United States and Europe, while AF impacts an estimated 2% to 6% of the global population. The AF catheter ablation market is currently valued at $5 billion and is projected to grow at a compound annual growth rate of 13% to 16%, surpassing $11 billion by 2034. In comparison, the global VT market— which includes devices and catheter ablation—was valued at approximately $12.5 billion in 2021 and is expected to grow at a compound annual growth rate of 5.26%, reaching $17 billion by 2027. Notably, the catheter ablation segment within the VT treatment market is projected to grow at a higher rate of 13% annually during this period, reflecting increased adoption of catheter-based interventions for VT management. Media ContactHolly Windler619.929.1275

Verimatrix and AgileTV Partner to Secure Fast-Growing TVaaS Solution
Verimatrix and AgileTV Partner to Secure Fast-Growing TVaaS Solution

Yahoo

time02-04-2025

  • Business
  • Yahoo

Verimatrix and AgileTV Partner to Secure Fast-Growing TVaaS Solution

AIX-EN-PROVENCE, France & SAN DIEGO & BILBAO, Spain, April 02, 2025--(BUSINESS WIRE)--Regulatory News: Verimatrix, (Euronext Paris: VMX), the leader in powering the modern connected world with people-centered security, today announced expanded collaboration with Bilbao, Spain-based AgileTV (BME: to provide the latest content security innovations for AgileTV's cloud-based TV-as-a-Service (TVaaS) Entertainment Hub, OTT and video delivery solutions designed to empower telcos, ISPs and media companies. By partnering with Verimatrix, which offers its vast portfolio of proven video security solutions including VCAS, Multi-DRM, Counterspy (watermarking) and DVB ReAccess, AgileTV gains a significantly streamlined path toward providing the most recent and reliable protection options to its global customer base. Through the collaboration, Verimatrix streamlines that protection process for AgileTV, enabling it to offer customers the ability to: Simplify the transition from legacy DVB and IPTV operations into hybrid or fully-fledged "nextgen" OTT service powered by AgileTV, thanks to the VCAS and DVB ReAccess capabilities to replace existing security providers. Confidently provides both existing and future needs surrounding highly-valuable premium content that demands specific protection, establishing Agile TVaaS as a vehicle to securely distribute and monetize content. Offer peace of mind for customers that prefer long-time industry innovators with a record of success in the content delivery network space. "Verimatrix is extremely pleased to further its collaboration with AgileTV, as it underscores our ability to efficiently arm such an innovative and successful TVaaS provider with the needed content security technologies that match today's ever-evolving video content delivery options," said Carlo Stramaglia, Head of Anti-Piracy Business at Verimatrix. "In the end, the repeatedly proven value we bring is to allow a partner such as AgileTV to focus on its core value proposition as TVaaS offering, while we closely work alongside them to ensure that security is strong and seamless. Consistently streamlining this content protection process is what we're proud to be known for in the industry. That's what makes Verimatrix a true business enabler for companies such as AgileTV." "AgileTV is proud to be recognized as a leader in the TVaaS space, offering solutions that combine a comprehensive and innovative TV technology suite with our best-in-class Operational Excellence Model", said Ruben Senor-Megias, Chief Sales officer at AgileTV. "Foundational to our product proposition is how we leverage on a "best-of-breed" partner ecosystem. In this sense, we are proud to announce our joint approach with Verimatrix, a leading Security Provider, which is key to our relentless focus on Content Security and revenue protection for our Content owners. Besides the existing collaboration for M-DRM, we believe Verimatrix VCAS and DVB ReAccess solutions are enablers to support customer transitions from legacy distribution solutions to advanced OTT solutions, thus improving the service for their customer base". In 2020, Verimatrix and AgileTV announced their collaboration to include Verimatrix Multi-DRM technologies within AgileTV offerings. About Agile TechnologiesAgileTV is a technology company providing end-to-end solutions for pay TV services over the Internet. Its customers include telecom providers, content creators, broadcasters and multimedia content management companies. The portfolio spans fully managed TV services, SaaS applications and infrastructure platforms, delivering innovative, cost-effective and scalable solutions for the TV business. With more than 300 professionals in 15 countries, AgileTV has over 20 years of experience, serving 120+ global clients and reaching more than 50 million households worldwide through its technologies. Headquartered in Bilbao, the company centralizes R&D&I activities, collaborating with international partners to revolutionize the television experience. Founded in 2007, AgileTV is a brand of Agile Content, listed on the BME Growth market since 2015. Visit About VerimatrixVerimatrix (Euronext Paris: VMX, FR0010291245) helps power the modern connected world with security made for people. We protect digital content, applications, and devices with intuitive, people-centered and frictionless security. Leading brands turn to Verimatrix to secure premium movies, live streaming sports, sensitive financial and healthcare data, mission-critical mobile applications, and much more. We enable the trusted connections our customers depend on to deliver compelling content and experiences to millions of consumers around the world. Verimatrix helps partners get to market faster, scale easily, protect valuable revenue streams, and win new business. Visit View source version on Contacts Verimatrix Investor: Jean-François Labadie, Chief Financial Officerfinance@ Verimatrix Media: Matthew AgileTV Media: Raquel Martínez Sign in to access your portfolio

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store